KRRO logo

Korro Bio (KRRO) Company Overview

Profile

Full Name:

Korro Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 3, 2019

Indexes:

Not included

Description:

Korro Bio, also known as KRRO, is a biotechnology company focused on developing RNA-targeted therapies. They aim to treat various diseases by using innovative approaches to modify RNA, which plays a crucial role in gene expression and protein production. Their work seeks to improve patient outcomes in medicine.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 5, 2025

Recent annual earnings:

Mar 5, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 6, 2023

Analyst ratings

Recent major analysts updates

Nov 22, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Jones Trading
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 21, 24 Raymond James
Strong Buy
Oct 21, 24 RBC Capital
Outperform
Oct 18, 24 HC Wainwright & Co.
Buy
Sep 19, 24 RBC Capital
Outperform
Sep 17, 24 HC Wainwright & Co.
Buy
Aug 14, 24 William Blair
Outperform
Aug 14, 24 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Korro Bio?
  • Does Korro Bio pay dividends?
  • What sector is Korro Bio in?
  • What industry is Korro Bio in?
  • What country is Korro Bio based in?
  • When did Korro Bio go public?
  • Is Korro Bio in the S&P 500?
  • Is Korro Bio in the NASDAQ 100?
  • Is Korro Bio in the Dow Jones?
  • When was Korro Bio's last earnings report?
  • When does Korro Bio report earnings?
  • Should I buy Korro Bio stock now?

What is the ticker symbol for Korro Bio?

The ticker symbol for Korro Bio is NASDAQ:KRRO

Does Korro Bio pay dividends?

No, Korro Bio does not pay dividends

What sector is Korro Bio in?

Korro Bio is in the Healthcare sector

What industry is Korro Bio in?

Korro Bio is in the Biotechnology industry

What country is Korro Bio based in?

Korro Bio is headquartered in United States

When did Korro Bio go public?

Korro Bio's initial public offering (IPO) was on October 3, 2019

Is Korro Bio in the S&P 500?

No, Korro Bio is not included in the S&P 500 index

Is Korro Bio in the NASDAQ 100?

No, Korro Bio is not included in the NASDAQ 100 index

Is Korro Bio in the Dow Jones?

No, Korro Bio is not included in the Dow Jones index

When was Korro Bio's last earnings report?

Korro Bio's most recent earnings report was on Mar 5, 2025

When does Korro Bio report earnings?

The date for Korro Bio's next earnings report has not been announced yet

Should I buy Korro Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions